Redian新闻
>
请问CRISPR比RNAi先进在哪些方面?
avatar
请问CRISPR比RNAi先进在哪些方面?# Biology - 生物学
t*o
1
EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
approval (approval notice mail
5/2).
Background: biomedical, senior research associate in Uni.
Publication 9 (7 1st author, IF up to 7);
Conference abstract 6;
Citation 120;
No award, no membership, no independent review (8 co-reviews with my boss);
7 reference letter 5 US, 1 Europe, 1 australia.
Claim: authorship, contribution, meidia report, judge the work of others.
Uni. hired attorney insisted to claim four. Review evidence is only from a
sentence mentioned in my boss's
reference letter. Media report is actually citations that heavily discussed
my work (my attorney thought it can
be called as media report).

Got a lot of useful information from this site. I will post all my petition
material later.
Thanks for you guys' blessing and best luck with all your petition.
avatar
p*0
2
RT
avatar
i*n
3
Cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
s*r
4
ko vs kd
stable vs transient

【在 p***0 的大作中提到】
: RT
avatar
b*r
5
恭喜
avatar
T*G
6
一个是genomic stable modification, 一个是transcripts level的change,哪个高大
上一下就看出来了

【在 p***0 的大作中提到】
: RT
avatar
m*q
7
cong

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
d*3
8
CRISPR的整合入基因组,难道不会引发肿瘤等 安全性能问题么?
avatar
d*e
9
GXGX!
avatar
l*9
10
如果基因敲除是致死的,RNAi的knock down是个克服办法。
avatar
IJ
11
cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
D*4
12
Cong
avatar
B*k
13
cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
l*t
14
恭喜

发信人: tianmaomao (tianmaomao), 信区: Immigration
标 题: EB1B I140 pp day7 NSC approved
发信站: BBS 未名空间站 (Tue May 3 22:29:05 2011, 美东)
EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
approval (approval notice mail
5/2).
Background: biomedical, senior research associate in Uni.
Publication 9 (7 1st author, IF up to 7);
Conference abstract 6;
Citation 120;
No award, no membership, no independent review (8 co-reviews with my boss);
7 reference letter 5 US, 1 Europe, 1 australia.
Claim: authorship, contribution, meidia report, judge the work of others.
Uni. hired attorney insisted to claim four. Review evidence is only from a
sentence mentioned in my boss's
reference letter. Media report is actually citations that heavily discussed
my work (my attorney thought it can
be called as media report).
Got a lot of useful information from this site. I will post all my petition
material later.
Thanks for you guys' blessing and best luck with all your petition.

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
R*d
15
gxgx
avatar
S*i
16
cong~

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
l*2
17
GX
avatar
d*3
18
CONG
不过你的英文可真麻烦,

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
p*h
19
big Cong!
avatar
f*2
20
big congrats!
job well done!
avatar
A*8
21
Cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
h*i
22
gxgx
avatar
o*o
23
GX!

to
boss);
others.

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
R*d
24
gxgx
avatar
m*r
25
cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
A*n
26
GONGXI!!!!!!!!!!!!!!!!!
avatar
q*2
27
GXGX!
avatar
y*9
28
恭喜
avatar
c*o
29
Big cong!

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
y*p
30
congrats
baozi plz
avatar
m*n
31
GX GX
avatar
s*g
32
congs!
avatar
b*s
33
恭喜了!
avatar
Y*Z
34
gxgx
avatar
n*w
35
Congrat!
avatar
b*d
36
gxgx
baozi

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
s*t
37
cong!
看来NSC也有一些正常的IO嘛。
avatar
m*s
38
gxgx......

boss);
others.

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

avatar
S*B
39
Cong! Congratulations! I am applying for eb1b too now. Company's lawyer
asked me to provide everything. Could you email me your copy of application
material?
To F*************[email protected]
Thanks
avatar
h*i
40
GXGX
avatar
d1
41
gx, mwbabti.

【在 t********o 的大作中提到】
: EB1B 140pp NSC received on 4/26/11, no nothing until tonight updated to
: approval (approval notice mail
: 5/2).
: Background: biomedical, senior research associate in Uni.
: Publication 9 (7 1st author, IF up to 7);
: Conference abstract 6;
: Citation 120;
: No award, no membership, no independent review (8 co-reviews with my boss);
: 7 reference letter 5 US, 1 Europe, 1 australia.
: Claim: authorship, contribution, meidia report, judge the work of others.

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。